Biomarkers in Cancer Immunotherapy: How Much Do They Matter?

If you're a patient interested in receiving cancer immunotherapy, you might hear the word "biomarkers" come up. They are an increasingly important area of study within the field of cancer immunotherapy research. These biological "signals" provide many clues for doctors to help them identify which patients are more likely to benefit from treatment and the duration of that benefit.

In this webinar for patients and caregivers, Dr. Haidong Dong of the Mayo Clinic discusses the role biomarkers play in making treatment decisions and delves into the latest research to identify new biomarkers. This webinar was recorded Tuesday, August 29, 2017.

The "Cancer Immunotherapy and You" webinar series is produced by the Cancer Research Institute and is made possible with generous support from Bristol-Myers Squibb, Genentech, Regeneron, and Advaxis. Browse our Cancer Immunotherapy and You Webinar Series playlist on YouTube to see other webinars in this series.